Abstract
Objective: To assess possible factors affecting the bone mineral density (BMD) in postmenopausal women. Methods: A retrospective analysis of 267 cases with spontaneous menopause within 3 years of period was performed. None of the enrolled cases were taken any hormone replacement therapy and/or treatment for osteoporosis. BMD measurements were done in lumbal vertebral (L1–L4) and left femur (neck, intertrochanteric and ward triangle) via dual energy X-ray absorbtiometry (DEXA) method, yielding corresponding T-scores of above-mentioned areas. In addition, age at menarche, parity, menopausal age, duration of postmenopausal state, lactation, physical activity, cigarette smoking, dietary calcium intake, oral contraceptive use and body mass index (BMI) were determined. Results: There were no relationships between BMD and age at menarche, parity, menopausal age, lactation, physical activity, smoking, dietary calcium intake and oral contraceptive use. Two associated factors with BMD were BMI and time since menopause. BMI was found to be positively and time since menopause was negatively correlated with BMD of both lumbal region and femur. Conclusions: BMD changes and its related factors should be kept in mind during postmenopausal years. Therefore, adequate peak bone mass and related life style measures should be achieved to confront osteoporosis-related symptoms and its consequences.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Consensus Development Conference (1993) Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646–650
Cummings SR, Kelsey JL, Nevitt MC, O’Dowd KJ (1985) Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 7:178–208
Kanis JA, Pitt FA (1992) Epidemiology of osteoporosis. Bone 13:7–15
Ross PD, Davis JW, Epstein RS, Wasnich RD (1991) Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114:919–923
Chung KW, Kim RW, Yoo SW, Kwon DJ, Tim YT, Kim JH, Lee JW (2000) Can bone turnover correlate bone mass at the hip and spine according to menopause period. Arch Gynecol Obstet 264:119–123
Fenkci V, Yilmazer M, Fenkci S (2003) Effects of short-term (3 months) tibolone treatment on bone turnover in postmenopausal women. Arch Gynecol Obstet 268(2):85–87
WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Tech Rep Series, 843
Kritz-Silverstein D, Barrett-Connor E (1993) Early menopause, number of reproductive years, and bone mineral density in postmenopausal women. Am J Public Health 83(7):983–988
Hu JF, Zhao XH, Chen JS, Fitzpatrick J, Parpia B, Campell TC (1994) Bone density and lifestyle characteristics in premenopausal and postmenopausal Chinese women. Osteoporos Int 4(6):288–297
Johnell O, Gullberg B, Kanis JA, Allander E, Elffors L, Dequeker J, Dilsen G, Gennari C, Lopes Vaz A, Lyritis G et al (1995) Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res 10(11):1802–1815
Kritz-Silverstein D, Barrett-Connor E, Hollenbach KA (1992) Pregnancy and lactation as determinants of bone mineral density in postmenopausal women. Am J Epidemiol 136(9):1052–1059
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Writing Group for the Women’s Health Initiative Investigators. Risk and benefits of estrogen and progestin in healthy postmenopausal women: principle results from the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333
Haruko Kawai, Madoka Furuhashi, Suganuma N (2004) Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy. Arch Gynecol Obstet 269(3):192–195
Acar B, Uslu T, Topuz A, Osma E, Ercal T, Posaci C, Erata Y, Mumcu A (1998) Relationship between bone mineral context and clinical, hormonal and biochemical parameters in postmenopausal women. Arch Gynecol Obstet 261(3):121–128
Krall EA, Dawson-Hughes B (1991) Smoking and bone loss among postmenopausal women. J Bone Miner Res 6(4):331–338
Kleerekoper M, Brienza RS, Schultz LR, Johnson CC (1991) Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group. Arch Intern Med 151(10):1971–1976
Prior JC, Kirkland SA, Joseph L, Kreiger N, Murray TM et al (2001) Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population based data from the Canadian Multicentre Osteoporosis Study. CMAJ 165(8):1023–1029
Bidoli E, Schinella D, Franceschi S (1998) Physical activity and bone mineral density in Italian middle-aged women. Eur J Epidemiol 14(2):153–157
Lacey JM, Anderson JJ, Fujita T, Yoshimoto Y, Fukase M, Tsuchie S, Koch GG (1991) Correlates of cortical bone mass among premenopausal and postmenopausal Japanese women. J Bone Miner Res 6(7):651–659
Ulrich U, Miller PB, Eyre DR, Chestnut CH 3rd, Bodenschatz C, Schlebusch H, Soules MR (2004) Short-term calcium supplementation has no effect on biochemical markers of bone remodeling in early postmenopausal women. Arch Gynecol Obstet 270(4):230–234
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hassa, H., Tanir, H.M., Senses, T. et al. Related factors in bone mineral density of lumbal and femur in natural postmenopausal women. Arch Gynecol Obstet 273, 86–89 (2005). https://doi.org/10.1007/s00404-005-0015-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-005-0015-0